|Articles|February 1, 2013
- BioPharm International-02-01-2013
- Volume 26
- Issue 2
BioPharm International, February 2013 Issue (PDF)
Viral Vaccines
Advertisement
Articles in this issue
about 13 years ago
Assessing Development Needs for Biobetters and Biosimilarsabout 13 years ago
Facility Design and Operation: A Primerabout 13 years ago
Offering a Biopharma View of Social Mediaabout 13 years ago
GMP Compliance Becomes Prominent Enforcement Issueabout 13 years ago
Therapeutic Antibodies in Reviewabout 13 years ago
The Vaccine Sceneabout 13 years ago
Automated Concentration and Diafiltration of Multiple siRNA Samplesabout 13 years ago
End of the Dedicated CMO?about 13 years ago
Viral Vaccine Manufacturingabout 13 years ago
Navigating Emerging Markets: Eastern EuropeNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
5